References
- ResnikoffSPascoliniDEtya’aleDGlobal data on visual impairment in the year 2002Bull World Health Organ20048284485115640920
- European Glaucoma SocietyTerminology and Guidelines for Glaucoma2nd edSavona, ItalyEd Dogma2003
- EmerickGTQuality of life and glaucoma medications. Do our proescriptions make a difference?Glaucoma Today200553839
- AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trialsJ Glaucoma20081766767319092464
- HonrubiaFGarcia-SanchezJPoloVde la CasaJMSotoJConjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomized clinical trialsBr J Ophthalmol20099331632119019922
- ZimmermanTJStewartWCLatanoprost Axis Study GroupIntra- ocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from monotherapy treatmentsJ Ocul Pharmacol Ther20031940541514583133
- BalkrishnanRBondJBByerlyWGCamachoFTMedication-related predictors of health-related quality of life in glaucoma patients enrolled in a Medicare health maintenance organizationAm J Geriatr Pharmacother20031758115555469
- HodappEParrishRKAndersonDRClinical Decisions in GlaucomaSt Louis, MOMosby1993
- SimaoLMLana-PeixotoMAAraújoCRMoreiraMATeixeiraALThe Brazilian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, reliability and validityArq Bras Oftalmol20087154054618797665
- SawadaHFukuchiTAbeHEvaluation of the relationship between quality of vision and visual function in Japanese glaucoma patientsClin Ophthalmol2011525926721468331
- JanzNKWrenPALichterPRThe Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucomaOphthalmology20011081954196511713062
- RamuluPGlaucoma and disability: which tasks are affected, and at what stage of disease?Curr Opin Ophthalmol200920929819240541
- SharmaSBrownGCBrownMMConverting visual acuity to utilitiesCan J Ophthalmol20003526727210959467
- NoeckerRJWaltJGCost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medicationsAm J Ophthalmol2006141S15S2116389056
- ReardonGSchwartzGFMozzafariEPatient persistency with topical ocular hypotensive therapy in a managed care populationAm J Ophthalmol2004137S3S1214697909
- ReardonGSchwartzGFKotakSPersistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapyBMC Opthahlmol201021015
- SuzukiERSuzukiCLEfficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerationsClin Ophthalmol2010211165117121060666
- HommerAA review of preserved and preservative-free prostaglandin analogues for the treatment of open angle glaucoma and ocular hypertensionDrugs Today (Barc)2010640941620571609